This trial will test the drug filgotinib for the treatment of small bowel Crohn’s disease

Update Il y a 5 ans
Reference: EUCTR2016-003179-23

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to evaluate the efficacy of filgotinib, when compared to placebo, in establishing clinical remission at Week 24


Inclusion criteria

  • Small Bowel Crohn's Disease,Vékonybelet érintő Crohn betegség

Links